• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗体是预防高致病性 spp. 气溶胶致死性感染的主要驱动因素。

Antibodies Are Major Drivers of Protection against Lethal Aerosol Infection with Highly Pathogenic spp.

机构信息

Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.

Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.

出版信息

mSphere. 2019 Jan 2;4(1):e00674-18. doi: 10.1128/mSphere.00674-18.

DOI:10.1128/mSphere.00674-18
PMID:30602525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6315082/
Abstract

and are the causative agents of melioidosis and glanders, respectively. There is no vaccine to protect against these highly pathogenic bacteria, and there is concern regarding their emergence as global public health () and biosecurity () threats. In this issue of , an article by Khakhum and colleagues (N. Khakhum, P. Bharaj, J. N. Myers, D. Tapia, et al., mSphere 4:e00570-18, 2019, https://doi.org/10.1128/mSphere.00570-18) describes a novel vaccination platform with excellent potential for cross-protection against both species. The report also highlights the importance of antibodies in immunity against these facultative intracellular organisms.

摘要

和 分别是类鼻疽和鼻疽的病原体。目前尚无针对这些高致病性细菌的疫苗,人们担心它们会成为全球公共卫生()和生物安全()威胁。在本期《mSphere》杂志上,Khakhum 等人(N. Khakhum、P. Bharaj、J. N. Myers、D. Tapia 等人,mSphere 4:e00570-18, 2019, https://doi.org/10.1128/mSphere.00570-18)描述了一种具有出色交叉保护两种 物种潜力的新型疫苗接种平台。该报告还强调了抗体在针对这些兼性细胞内生物的免疫中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3f5/6315082/0680866232b9/sph0011927380001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3f5/6315082/0680866232b9/sph0011927380001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3f5/6315082/0680866232b9/sph0011927380001.jpg

相似文献

1
Antibodies Are Major Drivers of Protection against Lethal Aerosol Infection with Highly Pathogenic spp.抗体是预防高致病性 spp. 气溶胶致死性感染的主要驱动因素。
mSphere. 2019 Jan 2;4(1):e00674-18. doi: 10.1128/mSphere.00674-18.
2
Antibodies against -Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.针对 - 表达抗原的抗体足以保护机体免受鼻疽伯克霍尔德菌和类鼻疽伯克霍尔德菌致死性气溶胶感染。
Infect Immun. 2017 Jul 19;85(8). doi: 10.1128/IAI.00102-17. Print 2017 Aug.
3
Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.使用一种安全、可重现且快速的气溶胶输送方法来研究小鼠感染类鼻疽伯克霍尔德菌和鼻疽伯克霍尔德菌。
PLoS One. 2013 Oct 2;8(10):e76804. doi: 10.1371/journal.pone.0076804. eCollection 2013.
4
Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.表达类鼻疽伯克霍尔德菌脂多糖O抗原的重组沙门氏菌在类鼻疽和鼻疽小鼠模型中提供保护作用。
PLoS One. 2015 Jul 6;10(7):e0132032. doi: 10.1371/journal.pone.0132032. eCollection 2015.
5
Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei.三种用于鼻疽(由鼻疽伯克霍尔德菌引起)的非人灵长类动物气溶胶模型的比较。
Microb Pathog. 2021 Jun;155:104919. doi: 10.1016/j.micpath.2021.104919. Epub 2021 Apr 27.
6
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.热灭活的泰国伯克霍尔德菌、鼻疽伯克霍尔德菌或类鼻疽伯克霍尔德菌对实验性类鼻疽和鼻疽的保护效力。
Vaccine. 2009 Jul 16;27(33):4447-51. doi: 10.1016/j.vaccine.2009.05.040. Epub 2009 May 31.
7
Development of Burkholderia mallei and pseudomallei vaccines.马鼻疽伯克霍尔德菌和类鼻疽伯克霍尔德菌疫苗的研制。
Front Cell Infect Microbiol. 2013 Mar 11;3:10. doi: 10.3389/fcimb.2013.00010. eCollection 2013.
8
Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis.鼻疽伯克霍尔德菌和类鼻疽伯克霍尔德菌:鼻疽和类鼻疽的致病微生物。
Recent Pat Antiinfect Drug Discov. 2007 Nov;2(3):233-41. doi: 10.2174/157489107782497335.
9
Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.评估马鼻疽缺陷型 TonB 缺陷型 Hcp1(CLH001)在马鼻疽和类鼻疽的鼠模型中的作为减毒活疫苗的效果。
PLoS Negl Trop Dis. 2019 Jul 15;13(7):e0007578. doi: 10.1371/journal.pntd.0007578. eCollection 2019 Jul.
10
Burkholderia pseudomallei Δ Δ Live Attenuated Vaccine Strain Elicits Full Protective Immunity against Aerosolized Melioidosis Infection.类鼻疽伯克霍尔德菌ΔΔ活减毒疫苗株可诱导针对气溶胶化类鼻疽感染的完全保护免疫。
mSphere. 2019 Jan 2;4(1):e00570-18. doi: 10.1128/mSphere.00570-18.

引用本文的文献

1
Decoration of Hcp1 protein to virus-like particles as a vaccine delivery platform.将Hcp1蛋白修饰到病毒样颗粒上作为一种疫苗递送平台。
Infect Immun. 2024 Mar 12;92(3):e0001924. doi: 10.1128/iai.00019-24. Epub 2024 Feb 14.
2
Shotgun Immunoproteomic Approach for the Discovery of Linear B-Cell Epitopes in Biothreat Agents and .利用 shotgun 免疫蛋白质组学方法发现生物威胁剂中的线性 B 细胞表位 。
Front Immunol. 2021 Sep 29;12:716676. doi: 10.3389/fimmu.2021.716676. eCollection 2021.
3
Human Melioidosis.类鼻疽病。

本文引用的文献

1
Burkholderia pseudomallei Δ Δ Live Attenuated Vaccine Strain Elicits Full Protective Immunity against Aerosolized Melioidosis Infection.类鼻疽伯克霍尔德菌ΔΔ活减毒疫苗株可诱导针对气溶胶化类鼻疽感染的完全保护免疫。
mSphere. 2019 Jan 2;4(1):e00570-18. doi: 10.1128/mSphere.00570-18.
2
Melioidosis.类鼻疽病。
Nat Rev Dis Primers. 2018 Feb 1;4:17107. doi: 10.1038/nrdp.2017.107.
3
Antibodies against -Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.
Clin Microbiol Rev. 2020 Mar 11;33(2). doi: 10.1128/CMR.00006-19. Print 2020 Mar 18.
针对 - 表达抗原的抗体足以保护机体免受鼻疽伯克霍尔德菌和类鼻疽伯克霍尔德菌致死性气溶胶感染。
Infect Immun. 2017 Jul 19;85(8). doi: 10.1128/IAI.00102-17. Print 2017 Aug.
4
Melioidosis: Clinical impact and public health threat in the tropics.类鼻疽:热带地区的临床影响与公共卫生威胁
PLoS Negl Trop Dis. 2017 May 11;11(5):e0004738. doi: 10.1371/journal.pntd.0004738. eCollection 2017 May.
5
Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?类鼻疽伯克霍尔德菌和鼻疽伯克霍尔德菌疫苗:我们离临床试验还有多远?
Vaccine. 2017 Oct 20;35(44):5981-5989. doi: 10.1016/j.vaccine.2017.03.022. Epub 2017 Mar 21.
6
Antibiotic resistance in Burkholderia species.伯克霍尔德菌属的抗生素耐药性。
Drug Resist Updat. 2016 Sep;28:82-90. doi: 10.1016/j.drup.2016.07.003. Epub 2016 Jul 30.
7
Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis.预测假鼻疽伯克霍尔德菌的全球分布和类鼻疽病负担。
Nat Microbiol. 2016 Jan 11;1:15008. doi: 10.1038/nmicrobiol.2015.8.
8
Glanders and the risk for its introduction through the international movement of horses.鼻疽以及马匹国际流动带来的引入风险。
Equine Vet J. 2016 Sep;48(5):654-8. doi: 10.1111/evj.12599. Epub 2016 Jul 22.
9
Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.类鼻疽和鼻疽对固有免疫系统的调节:当前及未来疫苗研发面临的障碍
Expert Rev Vaccines. 2016 Sep;15(9):1163-81. doi: 10.1586/14760584.2016.1170598. Epub 2016 Apr 20.
10
Mechanisms of Disease: Host-Pathogen Interactions between Burkholderia Species and Lung Epithelial Cells.疾病机制:伯克霍尔德菌属与肺上皮细胞之间的宿主-病原体相互作用
Front Cell Infect Microbiol. 2015 Nov 18;5:80. doi: 10.3389/fcimb.2015.00080. eCollection 2015.